EGFR and ovarian cancer: These appearances were de facto ultrastructural refinements of the images of chromatin degradation highlighted with fluorescence imaging recorded in the living ovarian cancer cells treated with the anti-EGFR or anti-EGFRvIII guided vectors for the hrDNases.